REGENERON PHARMACEUTICALS INC 4

Accession 0001237899-14-000079

$REGNCIK 0000872589operating

View on SEC.gov Company Profile

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:16 PM ET

Size

24.3 KB

Accession

0001237899-14-000079

Insider Transaction Report

Form 4

Period: 2014-11-24

REGENERON PHARMACEUTICALS INCREGN

GILMAN ALFRED G

Director

Transactions

Sale
Common Stock
2014-11-24$411.06/sh−4,140$1,701,788→ 0 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-11-24−15,000→ 0 total
Exercise: $24.41Exp: 2020-01-04→ Common Stock (15,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-11-24−10,000→ 5,000 total
Exercise: $57.11Exp: 2022-01-03→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2014-11-24$57.11/sh+10,000$571,100→ 40,000 total
Sale
Common Stock
2014-11-24$406.98/sh−6,327$2,574,962→ 29,073 total
Sale
Common Stock
2014-11-24$409.00/sh−7,500$3,067,500→ 11,640 total
Sale
Common Stock
2014-11-24$410.05/sh−7,500$3,075,375→ 4,140 total
Exercise/Conversion
Common Stock
2014-11-24$24.41/sh+15,000$366,150→ 15,000 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-11-24−15,000→ 0 total
Exercise: $33.42Exp: 2021-01-03→ Common Stock (15,000 underlying)
Exercise/Conversion
Common Stock
2014-11-24$33.42/sh+15,000$501,300→ 30,000 total
Sale
Common Stock
2014-11-24$405.65/sh−4,600$1,865,990→ 35,400 total
Sale
Common Stock
2014-11-24$407.93/sh−9,933$4,051,969→ 19,140 total

Footnotes (7)

[F1]Represents volume-weighted average price of sales of 4,600 shares of Company stock on November 24, 2014 at prices ranging from $405.28 to $406.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 24, 2014 at each separate price.
[F2]Represents volume-weighted average price of sales of 6,327 shares of Company stock on November 24, 2014 at prices ranging from $406.46 to $407.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 24, 2014 at each separate price.
[F3]Represents volume-weighted average price of sales of 9,933 shares of Company stock on November 24, 2014 at prices ranging from $407.51 to $408.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 24, 2014 at each separate price.
[F4]Represents volume-weighted average price of sales of 7,500 shares of Company stock on November 24, 2014 at prices ranging from $408.51 to $409.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 24, 2014 at each separate price.
[F5]Represents volume-weighted average price of sales of 7,500 shares of Company stock on November 24, 2014 at prices ranging from $409.51 to $410.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 24, 2014 at each separate price.
[F6]Represents volume-weighted average price of sales of 4,140 shares of Company stock on November 24, 2014 at prices ranging from $410.63 to $411.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 24, 2014 at each separate price.
[F7]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

→

Entity typeoperating

IncorporatedNY

Related Parties

filerCIK 0000872589

Filing Metadata

Form type: 4
Filed: Nov 24, 7:00 PM ET
Accepted: Nov 25, 4:16 PM ET
Size: 24.3 KB

View on SEC.gov